Prophylactic antimicrobial drugs to pregnant women colonized with group B streptococcus

Kristina Al’bertovna Oganyan; Ol’ga Nikolaevna Arzhanova; Alevtina Mikhaylovna Savicheva; Svetlana L’vovna Zatsiorskaya

doi:10.17816/JOWD64259-63

Journal of obstetrics and women's diseases ›› 2015, Vol. 64 ›› Issue (2) : 59 -63. DOI: 10.17816/JOWD64259-63

Articles

research-article

Prophylactic antimicrobial drugs to pregnant women colonized with group B streptococcus

Author information +

History +

PDF

Abstract

Group B streptococcus (GBS), Streptococcus agalactiae, are the causative agents of severe infection of the fetus and newborn child. The aim of the study was to evaluate the efficacy of antibacterial drugs in women in the III trimester of pregnancy for the prevention of B streptococcal infection. Studied during childbirth and the postpartum period, 70 women colonized by group B streptococcus, treated and not treated with antibacterial perparaty in the III trimester of pregnancy. Evaluated as a new-born children of these women. In pregnant women who received antibiotics in the III trimester of pregnancy, significantly fewer were delayed rupture of membranes, preterm labor, subinvolution uterus. Less common was marked asphyxia. Group B streptococcus significantly more frequently (in 43.5 % of cases) were identified in children born to mothers who did not receive antibiotics during pregnancy. In 26.1 % of these children diagnosed with intrauterine infection. Thus, the use of antimicrobials in the III trimester of pregnancy in detecting GBS in the urine in any quantity, simultaneous detection of these microorganisms in urine and vaginal discharge of a concentration of greater than 104 CFU/ml reduces the rate of preterm birth, postpartum complications, and neonatal asphyxia and intrauterine infection B streptococcal etiology.

Keywords

group B streptococcus / colonization of newborns / intrauterine infection / antibiotic therapy

Cite this article

Download citation ▾

Kristina Al’bertovna Oganyan, Ol’ga Nikolaevna Arzhanova, Alevtina Mikhaylovna Savicheva, Svetlana L’vovna Zatsiorskaya. Prophylactic antimicrobial drugs to pregnant women colonized with group B streptococcus. Journal of obstetrics and women's diseases, 2015, 64(2): 59-63 DOI:10.17816/JOWD64259-63

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Анкирская А. С. Роль стрептококков группы В в перинатальной патологии. Акушерство и гинекология. 1984; 9: 6-10.

[2]	Зациорская С. Л. В-стрептококковая инфекция у новорожденных детей в зависимости от массивности колонизации. Актуальные вопросы физиологии и патологии репродуктивной функции женщин: Материалы XXII научной сессии НИИ акушерства и гинекологии. Айламазяна Э. К., ред. СПб.; 1993; 61-3.

[3]	Оганян К. А. Течение и исход беременности при колонзации мочеполового тракта женщин стрептококками группы В и D. Дис. канд. мед. наук. СПб.; 2008.

[4]	Тотолян А. А. Стрептококки группы В в патологии человека. Тотолян А. А., ред. СПб.: Человек; 2009.

[5]	Baker C. J. Group B streptococcal infections. In infectious diseases of the fetus and newborn infant. The W. B. Saunders Co. 3rd ed. Philadelphia; 2004: 980-1054.

[6]	Crespo-Ortiz Mdel P. Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study. BMC Infect Dis; 2014: 428.

[7]	Domelier A. S. Loss of Catabolic Function in Streptococcus agalactiae Strains and Its Association with Neonatal Meningitis. J. Clin. Microbiol. 2006; 44: 3245-50.

[8]	Edwards M. S. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 2005; 41: 839-47.

[9]	Faxelius G. Neonatal septicemia due to group B streptococci - perinatal risk factors and outcome of subsequent pregnancies. J. Perinat. Med. 1988; 16: 423-30.

[10]	Gilson G. J. Prevention of group B streptococcus early-onset neonatal sepsis: comparison of the Centers for Disease Control and Prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks' gestation. J. Perinatol. 2000; 20: 491-5.

[11]	Matorras R. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 1991; 40: 57-2.

[12]	Mahieu L. Management of the neonate at risk for early-onset Group B streptococcal disease (GBS EOD): new paediatric guidelines in Belgium. Acta Clin Belg: 2014; 69 (5): 313-9.

[13]	Ohlsson A. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev: 2014; CD007467.

[14]	Provisional Recommendations for the Prevention of Perinatal Group B Streptococcal Disease Date of posting of provisional recommend. Guidelines in CDC Morb. and Mortal. Wkly Rep. 2010.